C.R. Bard Inc., a multinational medical device company, agreed to pay $48.2 million to the federal government to settle a whistleblower lawsuit alleging illegal Medicare kickbacks. The case exposed how Bard’s urological division and its wholly owned subsidiary, ProSeed Inc., paid doctors and hospitals kickbacks to push Bard’s products at inflated prices for treating Medicare patients with prostate cancer.
A whistleblower represented by Wilbanks & Gouinlock (W&G) provided hundreds of key documents proving Bard’s involvement in an illegal Medicare kickback scheme. These kickbacks created improper financial incentives, leading to Medicare overbilling and violations of federal fraud laws.
The Medicare kickback lawsuit resulted in a $48.2 million settlement, holding Bard accountable for its fraudulent financial practices. This case serves as a landmark example of how whistleblowers help expose corporate fraud in the healthcare industry.
If you have information about fraudulent practices, contact our office for a free, confidential consultation:
This article is for informational purposes only and should not be considered legal advice.
To determine whether you have a potential case, please complete the Case Evaluation form by clicking the button above, and a member of our team will contact you as soon as possible. To learn more about whistleblower protections, click here.
You don’t have to go it alone. Our attorneys have successfully represented whistleblowers in some of the largest fraud cases in the country, delivering real results while protecting our clients. Take the first step today.